HRHarrow Health, Inc. HROW · NASDAQ
$27.68 +1.47% (+$0.40)
- Market cap
- $1.04B
- Enterprise value
- $1.25B
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 3.8x
- P/FCF
- 182.5x
- EV/EBITDA
- 279.8x
- ROIC
- 2.0%
- Bruto marža
- 73.3%
- Neto marža
- -13.5%
- Dividend yield
- -
- Payout ratio
- -
- Neto dolg/EBITDA
- 48.4x
- Beta
- 0.24
- Free float
- 77.2%
O podjetju
Harrow Health, Inc. is a pharmaceutical company primarily focused on providing affordable and innovative drugs and healthcare products. The company specializes in the development and commercialization of pharmaceuticals and medical devices in the fields of ophthalmology, dermatology, and neurology. Their portfolio includes a wide range of therapeutic products, including generics, branded drugs, and medical devices, aimed at treating various health conditions and diseases. Harrow Health, Inc. focuses on providing affordable and quality medications for patients and strengthening its position in the pharmaceuticals and healthcare products market.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mark L. Baum
Employees
373
Headquarters
Nashville
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke